Protective effect of epigallocatechin-3-gallate (EGCG) on toxic metalloproteinases-mediated skin damage induced by Scyphozoan jellyfish envenomation

• Published in: Scientific reports 2020-10, Vol.10 (1), p.18644, Article 18644
• Main Authors: Hwang, Du Hyeon, Lee, Hyunkyoung, Choudhary, Indu, Kang, Changkeun, Chae, Jinho, Kim, Euikyung
• Format: Article
• Language: English
• Subjects: 631/154; 692/308; 692/4017; 692/700; Animals; Catechin - analogs & derivatives; Catechin - therapeutic use; Cell culture; Cell Line; Cnidaria; Cnidarian Venoms - toxicity; Cytotoxicity; Epigallocatechin gallate; Gelatinase A; Gelatinase B; Green tea; Humanities and Social Sciences; Humans; Matrix metalloproteinase; Matrix Metalloproteinase 2 - metabolism; Matrix Metalloproteinase 9 - metabolism; Metalloproteinase; multidisciplinary; Polyphenols; Public health; Science; Science (multidisciplinary); Scyphozoa - chemistry; Skin Diseases - drug therapy; Snakes; Toxins; Venom
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-75269-1

Jellyfish stingings are currently raising serious public health concerns around the world. Hence, the search for an effective first aid reagent for the envenomation has been the goal of many investigators in the field. There have been a few previous reports of in vivo as well as in vivo studies suggesting the metalloproteinase activity of scyphozoan jellyfish venom, such as N. nomurai venom (NnV), plays a major role in the pathogenesis. These results have inspired us to develop a metalloproteinase inhibitor as a candidate for the treatment of Scyphozoan jellyfish envenomation. It has been previously demonstrated that the major polyphenol component in green tea, epigallocatechin-3-gallate (EGCG), can inhibit metalloproteinase activity of snake venoms. In fact, plant polyphenols as potential therapeutics have been shown to exert positive effects on neutralizing snake venoms and toxins. In the present study, we found that EGCG significantly inhibits the toxic proteases of NnV in a concentration-dependent manner. Human keratinocyte (HaCaT) and Human dermal fibroblast (HDF) cell culture studies showed that EGCG treatment can protect the cells from NnV-induced cytotoxicity which has been accompanied by the down-regulation of human matrix metalloproteinase (MMP)-2 and -9. Simulated rat NnV envenomation study disclosed that topical treatments with EGCG considerably ameliorated the progression of the dermonecrotic lesions caused by NnV. EGCG also reduced the activitions of tissue MMP-2 and MMP-9, which seem to be crucial players in the dermal toxic responses induced by NnV. Therefore, we propose that EGCG might be an effective therapeutic agent for the treatment of cutaneoous jellyfish symptoms.